Talquetamab + teclistamab in patients with triple-class exposed R/R MM and EMD: The RedirecTT-1 study Talquetamab + teclistamab in patients with triple-class exposed R/R MM and EMD: The RedirecTT-1 study June 2025 Congress News Read more
2020 June EHA 2020 PODCAST: prof. dr. Arnon Kater about venetoclax monotherapy in CLL patients Read more
2020 June EHA 2020 PODCAST: dr. Efstathios Kastritis about the use of daratumumab in AL amyloidosis Read more
2020 June EHA 2020 PODCAST: prof. Tiziano Barbui about ropeginterferon in patients with polycythemia vera Read more
2020 May Clinical trials 100% response to new CAR-T cell therapy in R/R multiple myeloma patients Read more
Top
